Hetal A Sarvaiya from Foster City, CA, age 46

Resumes

Talati

view source

Location:

San Mateo, CA

Industry:

Electrical/Electronic Manufacturing

Work:

Taluka Panchayat Dhrangdhra
Talati

Education:

Vishwakarma Govt Engineering College 2010 - 2013
Bachelors, Electronics

Interests:

Eating
Sleeping
Playing Logical Games
Drawing
Playing Playcards

Associate Director, Dmpk-Ba

view source

Location:

San Francisco, CA

Industry:

Biotechnology

Work:

Abbvie
Associate Director, Dmpk-Ba
Stemcentrx, Inc.
Associate Director, Mass Spectrometry, Process Sciences
Stemcentrx, Inc.
Senior Scientist Iii
Merck Jan 2017 - Aug 2017
Senior Scientist
Merck Nov 2014 - Dec 2016
Scientist

Education:

Virginia Tech 2004 - 2006
Master of Science, Masters, Biomedical Engineering Saurashtra University, Rajkot
Masters, Master of Arts

Skills:

Proteomics
Hplc
Biotechnology
Assay Development
Chromatography
Protein Chemistry
Biomarkers
Mass Spectrometry
Lc Ms
Elisa
Characterization
Cell Culture
Life Sciences
Microfluidics
Cell
In Vivo
High Performance Liquid Chromatography
Monoclonal Antibodies

Hetal Sarvaiya 363310, US

view source

Work:

Satellite Electronics

Apr 2014 to 2000
support executive

Education:

VISHWAKARMA ENGINEERING COLLEGE, CHANDKHEDA
Ahmedabad, Gujarat
2009 to 2013
B.E in ELECTRONICS AND COMMUNICATION sardar patel vidyalaya
dhrangdhra
b.e,electronics and communication in electronics and communication

Skills:

ELECTRONICS, AUTOCAD 2D AND 3D, MICROCONTROLLER, COMMUNICATION,

Us Patents

Gal Alpha 1-3Gal-Containing N-Glycans In Glycoprotein Products Derived From Cho Cells
view source
US Patent:

20110045496, Feb 24, 2011
Filed:

Jan 22, 2009
Appl. No.:

12/529109
Inventors:

Carlos Bosques - Arlington MA, US
Jennifer Murphy - Marshfield MA, US
Hetal Sarvaiya - Quincy MA, US
Nathaniel Washburn - Belmont MA, US
Cuihua Liu - Belmont MA, US
International Classification:

G01N 33/53
C12Q 1/02
US Classification:

435 721, 435 29
Abstract:

The present invention provides methods of evaluating CHO cells.

Isotopically-Labeled Glycans
view source
US Patent:

20110213137, Sep 1, 2011
Filed:

Apr 15, 2008
Appl. No.:

12/595888
Inventors:

Carlos J. Bosques - Arlington MA, US
Ian Christopher Parsons - Belmont MA, US
Brian Edward Collins - Arlington MA, US
Hetal Sarvaiya - Quincy MA, US
Assignee:

MOMENTA PHARMACEUTICALS, INC. - CAMBRIDGE MA
International Classification:

C07B 59/00
G01N 30/72
C12Q 1/02
US Classification:

536 553, 436 94, 435 29
Abstract:

The present disclosure provides methods of making isotopically-labeled glycans or a mixture of glycans (e.g., a glycan preparation) via reductive amination. Such methods are useful, for example, in the determination of the relative amounts of a glycan species present in two or more glycoprotein preparations using mass spectroscopy. In one aspect, the present disclosure provides a method of making an isotopically-labeled glycan by a glycan with an amine and an isotopically-labeled reducing agent to provide an isotopically-labeled aminated glycan. In certain embodiments, the amine is an isotopically-labeled amine.

Gal Alpha 1-3Gal-Containing N-Glycans In Glycoprotein Products Derived From Cho Cells
view source
US Patent:

20140045212, Feb 13, 2014
Filed:

Oct 17, 2013
Appl. No.:

14/056674
Inventors:

Jennifer Murphy - Marshfield MA, US
Hetal Sarvaiya - Quincy MA, US
Nathaniel Washburn - Belmont MA, US
Cuihua Liu - Belmont MA, US
Assignee:

Momenta Pharmaceuticals, Inc. - Cambridge MA
International Classification:

C12P 21/00
US Classification:

435 691
Abstract:

The present invention provides methods of evaluating CHO cells.

Sialylated Glycoproteins
view source
US Patent:

20210277438, Sep 9, 2021
Filed:

Nov 20, 2020
Appl. No.:

17/100428
Inventors:

- Cambridge MA, US
Robin Meccariello - Brighton MA, US
Jonathan C. Lansing - Reading MA, US
Daniel Ortiz - Stoneham MA, US
Hetal Sarvaiya - Foster City CA, US
Nathaniel J. Washburn - Littleton MA, US
International Classification:

C12P 21/00
C12N 9/10
C07K 16/00
C12Q 1/48
Abstract:

Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.

Methods And Compositions For The Diagnosis And Treatment Of Kawasaki Disease
view source
US Patent:

20210116462, Apr 22, 2021
Filed:

Apr 6, 2020
Appl. No.:

16/841575
Inventors:

- Cambridge MA, US
Carlos J. Bosques - Cambridge MA, US
Jay Duffner - Shirley MA, US
Leona E. Ling - Winchester MA, US
Hetal Sarvaiya - Foster City CA, US
International Classification:

G01N 33/68
A61K 31/727
A61K 38/17
A61K 39/395
Abstract:

The present invention relates to the determination of levels or expression of particular biomarkers in biological samples which can be utilized to diagnose, prognose, and treat Kawasaki disease in subjects, and further to select subjects who would benefit from a Kawasaki disease therapy other than, or in addition to, IVIG treatment. Accordingly, the present invention encompasses methods and compositions that utilize these biomarkers for the diagnosis, prognosis, and treatment of Kawasaki disease.

Sialylated Glycoproteins
view source
US Patent:

20210040527, Feb 11, 2021
Filed:

Sep 25, 2020
Appl. No.:

17/032994
Inventors:

- Cambridge MA, US
Robin Meccariello - Brighton MA, US
Jonathan C. Lansing - Reading MA, US
Daniel Ortiz - Stoneham MA, US
Hetal Sarvaiya - Foster City CA, US
Nathaniel J. Washburn - Littleton MA, US
International Classification:

C12P 21/00
C12N 9/10
C07K 16/00
C12Q 1/48
Abstract:

Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.

Sialylated Glycoproteins
view source
US Patent:

20210017563, Jan 21, 2021
Filed:

Sep 25, 2020
Appl. No.:

17/033452
Inventors:

- Cambridge MA, US
Robin Meccariello - Brighton MA, US
Jonathan C. Lansing - Reading MA, US
Daniel Ortiz - Stoneham MA, US
Hetal Sarvaiya - Foster City CA, US
Nathaniel J. Washburn - Littleton MA, US
International Classification:

C12P 21/00
C12N 9/10
C07K 16/00
C12Q 1/48
Abstract:

Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.

Sialylated Glycoproteins
view source
US Patent:

20200032312, Jan 30, 2020
Filed:

Oct 1, 2019
Appl. No.:

16/589634
Inventors:

- Cambridge MA, US
Robin Meccariello - Brighton MA, US
Jonathan C. Lansing - Reading MA, US
Daniel Ortiz - Stoneham MA, US
Hetal Sarvaiya - Foster City CA, US
Nathaniel J. Washburn - Littleton MA, US
International Classification:

C12P 21/00
C12N 9/10
C07K 16/00
C12Q 1/48
Abstract:

Glycoproteins having particular sialylation patterns, and methods of making and using such glycoproteins, are described.